Free press releases distribution network?

Agency / Source: AnaSpec, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Industry’s First West Nile Virus Protease Assay Kits - While West Nile virus (WNV) has had significant outbreaks throughout the world since it was first identified, commercially available assay kits for the detection of WNV protease inhibitors had not been developed until now
Industry’s First West Nile Virus Protease Assay Kits

 

PRZOOM - /newswire/ - San Jose, CA, United States, 2007/05/15 - While West Nile virus (WNV) has had significant outbreaks throughout the world since it was first identified, commercially available assay kits for the detection of WNV protease inhibitors had not been developed until now.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

With the SensoLyte™ series of WNV Protease Assay Kits AnaSpec, a worldwide provider of integrated proteomics solutions, has introduced the industry’s first commercially available assay kits for the detection of WNV protease NS3 inhibitors.

West Nile virus (WNV), from the family Flaviviridae, 1 was first identified in the West Nile district of Uganda in 1937. 2 WNV outbreaks have been reported in Israel in the 50’s, France in the 60’s and South Africa in the 70’s. 3 In 1999, the first documented WNV infection in the US was reported in New York. 4 The main route of human infection is through infected mosquito bites. WNV infection can cause severe neurological disease and fatalities in both human and animal hosts.

WNV contains a single-stranded, positive-sense RNA genome, which encodes three structural proteins (capsid (C), membrane (M), envelope (E)), and seven non-structural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B, NS5). 5, 6 NS3 protease is essential (along with viral-encoded cofactor NS2B) for post-translational processing of a viral polypeptide precursor in infected host cells. This polypeptide provides the structural and functional viral proteins. Inhibition of its processing could represent a potential treatment for viral infections. With no effective vaccine or antiviral drug to protect against WNV infection,7 this protease represents a potentially key target for developing anti-WNV drugs.8, 9

The SensoLyte™ AMC West Nile Virus Protease Assay Kit provides a homogeneous assay for high throughput screening of West Nile Virus protease NS3 inhibitors. Utilizing a fluorogenic peptide, it provides continuous measurement and quantification of protease activity.10 Depending on the kit, the peptide generates the AMC (7-amino-4-methylcoumarin) or TAMRA fluorophore upon NS3 protease cleavage. AMC has bright blue fluorescence that can be detected with excitation at 354 nm and emission at 442 nm. TAMRA has red fluorescence that can be detected with excitation at 541 nm and emission at 568 nm.

R&D Manager, Dr. Rich Meyer, noted, “AnaSpec is committed to being a leader in the development of novel assay kits for our customers. The introduction of our SensoLyte™ WNV Protease Assay Kits is representative of this dedication to innovation.”

There are two available versions of the SensoLyte™ West Nile Virus Protease Assay Kits:

• SensoLyte™ 440 West Nile Virus Protease Assay Kit
• SensoLyte™ 570 West Nile Virus Protease Assay

Company Information

AnaSpec, Inc. (anaspec.com) is a leading provider of integrated proteomics solutions to pharmaceutical, biotech, and academic research institutions throughout the world. With a vision for innovation through synergy, AnaSpec focuses on three core technologies: peptides, detection reagents (dyes, assay kits, & antibodies), and combinatorial chemistry. Established in 1993, AnaSpec's ISO9001:2000 certified headquarters and manufacturing facilities are located in San Jose, CA.

References:
1. Hayes, CG. Ann. N.Y. Acad. Sci. 951, 25 (2001)
2. Smithburn, KC, et al. Am J Trop Med. 20, 471 (1940)
3. Internet. accessed April 13, 2007
4. Klee, AL. et al. Emerg Infect Dis.10, 1405 (2004)
5. Brinton, MA. Annu. Rev. Microbiol. 56, 371 (2002)
6. Lanciotti, RS. et al., Science 286, 2333 (1999)
7. van der Meulen, KM et al., Arch. Virol. 150, 637 (2005)
8. Mueller, NH. et al., Int. J.Biochem.Cell Biol. 39(3), 606 (2007)
9. Shiryaev, SA. et al., Biochem.J 393, 503 (2006)
10. Chappell, KJ. et al., J. Biol. Chem. 281, 38448 (2006)

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: AnaSpec, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Industry’s First West Nile Virus Protease Assay Kits

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Ping 
408-452-5055 ping[.]anaspec.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any AnaSpec, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From AnaSpec, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine
Somatuline® Autogel® 120 Mg Receives Japanese Approval for A New Indication for the Treatment of Gastro-entero-pancreatic Neuroendocrine Tumors
OTC Topical Drugs Market Size will Grow Profitably in the Near Future 2017-2025 Finds PMR
Bioinformatics Market Size to Expand at 20.4% CAGR through 2020 Reports Persistence Market Research
Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  S&A Capital Partner Ltd

Visit  MagLar, Inc.

Visit  La Bella Bakery Artisan Bakery Arizona







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today